AmREIT Announces Pricing of Public Offering of 3.0 Million Shares of Common Stock At $18.25

AmREIT, Inc.

(the “Company”) today announced the pricing of its public offering of 3,000,000 shares of its common stock at a public offering price of $18.25 per share, for net proceeds of approximately $52.1 million, after deducting underwriting discounts and commissions and other estimated offering expenses. The Company also granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock at the public offering price, less the underwriting discount, to cover over-allotments, if any. The offering is expected to close on or about July 19, 2013, subject to customary closing conditions. Jefferies is acting as sole book-running manager and Baird is acting as lead manager for the offering. Capital One Securities, PNC Capital Markets LLC and SunTrust Robinson Humphrey are acting as co-managers. The Company intends to use the net proceeds from the offering to repay borrowings outstanding under its unsecured revolving credit facility, to fund all or a portion of the acquisition of the fee simple interest in its Preston Royal East property, to fund a portion of the acquisition of Woodlake Square from its joint venture partner and two of its advised funds, and for general corporate purposes. The offering is being conducted as a public offering under the Company's effective shelf registration statement filed with the Securities and Exchange Commission (File No. 333-189525). A preliminary prospectus supplement related to this public offering has been filed with the Securities and Exchange Commission and a final prospectus supplement will be made available. Copies of the preliminary prospectus supplement, the final prospectus supplement (when available) and the related base prospectus may be obtained by contacting Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 12th Floor, New York, NY 10022, or by telephone toll free at (877) 547-6340 or by email at Prospectus_Department@Jefferies.com. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About AmREIT, Inc. AmREIT believes it has one of the highest quality grocery and drugstore anchored retail portfolios in the REIT sector. AmREIT's 29 year-old established platform has localized acquisition, operation and redevelopment expertise in the most densely populated and affluent submarkets of five of the top markets in the U.S.: Houston, Dallas, San Antonio, Austin and Atlanta. AmREIT's management team has in-depth knowledge and extensive relationship advantages within its markets. AmREIT's portfolio was 96.5% occupied as of March 31, 2013, and its top five tenants include Kroger, Landry's, CVS/Pharmacy, H-E-B, and Publix. AmREIT also has access to an acquisition pipeline through its value add joint ventures, including three leading institutional investors who partner with the company as local experts. AmREIT's common stock is traded on the New York Stock Exchange under the symbol “AMRE.” For more information, please visit www.amreit.com.